PDS Biotechnology Corp Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PDS Biotechnology Corp stock issued during period, shares, new issues for the quarter ending 2024-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- PDS Biotechnology Corp stock issued during period, shares, new issues for the quarter ending 2024-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- PDS Biotechnology Corp stock issued during period, shares, new issues for the quarter ending 2024-03-31 was 3.43M shares, a 519.69% increase year-over-year.
- PDS Biotechnology Corp stock issued during period, shares, new issues for the quarter ending 2023-12-31 was 1.91M shares.
- PDS Biotechnology Corp stock issued during period, shares, new issues for fiscal 2022 was 1.24M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-14 | 5.33M shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-13 | 5.47M shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-03-31 | 3.43M shares 10-Q · filed 2024-05-15 | 5.52M shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-12-31 | 1.91M shares derived: 10-Q 12 month − 10-Q 9 month · filed 2024-11-14 | 2.64M shares 10-Q · filed 2024-11-14 |
| 2023-09-30 | 139.57K shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 43.17K shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 553.29K shares 10-Q · filed 2024-05-15 | |
| 2022-12-31 | 1.24M shares 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |